Balchem Corporation (FRA:BL9B)

Market Cap	4.64B -8.3%
Revenue (ttm)	863.85M +7.6%
Net Income	127.17M +22.8%
EPS	3.89 +22.5%
Shares Out	n/a
PE Ratio	36.48
Forward PE	30.91
Dividend	0.82 (0.59%)
Ex-Dividend Date	Dec 23, 2025

Volume	n/a
Average Volume	5
Open	136.10
Previous Close	138.60
Day's Range	136.10 - 138.60
52-Week Range	118.60 - 167.20
Beta	n/a
RSI	59.75
Earnings Date	Feb 20, 2026

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipi...

• Industry: Industrial Organic Chemicals
• Founded: 1967
• Employees: 1,355
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BL9B

Financial Performance

In 2024, Balchem's revenue was $953.68 million, an increase of 3.39% compared to the previous year's $922.44 million. Earnings were $128.48 million, an increase of 18.36%.

Financial numbers in USD